Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Emily Conron
State of the Union HIV pledge links a “once-distant dream” to “scientific breakthroughs”

On February 5, President Trump delivered his second State of the Union address. Among the long list of policy proposals and pledges in the speech was one of great interest to the global health research community—an announcement of a new whole-of-government plan to eliminate HIV transmission in the United States by 2030.

Recent

National Institute of Allergy and Infectious Diseases (NIAID)
Research Roundup: TB drug development, mosquitoes’ secret weapon, and a new platform for antibiotic R&D

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Aaron Joel Santos
Celebrating over a decade of global health R&D advocacy

From humble origins to the premier advocacy organization focused on global health R&D. We tell the story of the birth of GHTC.

Read More
Architect of the Capitol
Research Roundup: Priority Review Voucher legislation, Toxic Shock Syndrome vaccine, and repurposing existing drugs

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: Schistosomiasis drug resistance, a nanotechnology vaccine platform, and adjusting doses to bolster the yellow fever vaccine supply

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Gabe Bienczycki
Research Roundup: Diagnostics for malaria, premature birth, and women’s health

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
US Navy
Senate votes to protect medical research at DoD

Today the US Senate voted to protect critical medical research programs at the Department of Defense (DoD).

GHTC
Read More
GHTC/Matthew Robinson
One week of WHA, extensive debate, and two key R&D decisions

As happens every May, the World Health Organization’s (WHO) highest governing body, the World Health Assembly (WHA), met last week for its 69th annual meeting in Geneva, Switzerland. The agenda was the most packed in recent memory, consisting of more than 70 discussion items, many of which were controversial. Despite the lengthy agenda and difficult conversations, the WHA made two key decisions impacting global health research and development (R&D).

Read More
PATH
Research Roundup: Antimicrobial R&D, pandemic insurance, and Zika countermeasures

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
David Dorward / National Institute of Allergy and Infectious Diseases
Research Roundup: antimicrobial resistance, microbiomes, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
WHO
WHO's doing WHA for the 69th time next week!

This coming week the “who’s who” of the global health community (as well as some much more modest global health advocates such as your humble author) will make the annual trek to Geneva, Switzerland, for the 69th World Health Assembly (WHA), where World Health Organization (WHO) member states will collectively decide WHO’s plans for the coming year.

Read More
PATH/Glenn Austin
Research Roundup: New insights into Zika virus, using silk to preserve blood samples, and a single dose oral cholera vaccine

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Jan Jacobs
Research Roundup: a rapid diagnostic for Ebola and fighting mosquito-borne diseases with soap and coconuts

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Doune Porter
Research Roundup: Yellow fever vaccine availability, protective antibodies against HIV, and the impact of past dengue infection on Zika fever

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Lesley Reed
Incentives and innovative financing mechanisms matter in addressing market failures

When existing market forces alone fall short in ensuring availability of and access to lifesaving health tools, a range of interventions are needed to alter the market and ultimately change the behavior of its actors.

GHTC
Read More
GHTC/Marissa Chmiola
GHTC briefing highlights critical role of US government in advancing global health innovation in an increasingly globalized world

On Tuesday, GHTC launched our seventh annual policy report through a congressional briefing and panel discussion. The critical role played by the US government in catalyzing global health research and development was a recurring theme, as panelists discussed the interconnectedness of global and American health and emphasized the need for new health tools to protect against outbreaks and continue progress.

GHTC
Read More
PATH/A. Golden
Research Roundup: an affordable hepatitis C regimen, rapid diagnostics for neglected diseases, and fighting Zika with tires and milk

GHTC member the Drugs for Neglected Diseases initiative will test an affordable hepatitis C regimen in Malaysia and Thailand, with a guarantee from generic drug manufacturer Pharco Pharmaceuticals that, if successful, the product will be priced at no more than US$294 for the entire regimen.

GHTC
Read More
Funding by crisis is no cure for global health threats

The Zika virus outbreak reinforces the need for US policymakers to stop funding by crisis and commit to sustainable, long-term investment in global health R&D.

GHTC
Read More
Research Roundup: legislation to expedite antibiotic R&D, a graduated approach to drug patents, and more

Scientists have described the first “teenage” broadly neutralizing antibody—an early stage version of the molecule, before developing the traits that make it effective against manifold HIV strains.

GHTC
Read More
President will redirect Ebola funds for Zika, but where is the money from and where will it go?

The Administration announced that it will transfer nearly $600 million in remaining Ebola funds to fight the growing threat of Zika virus. But many questions remain. Where is the money going? What accounts is it coming from? And what does this mean for the Global Health Security Agenda?

GHTC
Read More
Research Roundup: Mosquitos and mice in the fight against Zika

Is it feasible or wise to eradicate mosquitoes? Could genetically-modified mosquitoes help researcher tackle the Zika virus? Learn more in this week's Research Roundup.

GHTC
Read More